LTP LTR Pharma Ltd
- 0.840
- -0.010-1.18%
LTR Pharma Ltd News
LTR Pharma Pairs With Men's Health Downunder for Supply of Erectile Dysfunction Spray
LTR Pharma's JV Partner Launches Online Health Platform Ahead of Target
LTR Pharma Joins Forces to Launch Men's Health Platform
LTR Pharma Ltd: Annual Report to shareholders
LTR Pharma's SPONTAN 'Nasal Viagra' Absorbed 470% Times Faster Than Oral Solution
LTR Pharma Limited's (ASX:LTP) Biggest Owners Are Private Companies Who Got Richer After Stock Soared 14% Last Week
LTR Pharma Ltd: FY24 Results Announcement
LTR Pharma Ltd: Appendix 4E and Annual Financial Report
LTR Pharma Prescribes Erectile Dysfunction Medication Under Special Access Scheme
Why Is This ASX Small Cap Ripping 37% Ahead on Tuesday?
LTR Pharma, Aptar Pharma Enter Co-Development Agreement for SPONTAN Nasal Spray; LTR Shares Jump 18%
LTR Pharma Prescribes Erectile Dysfunction Medication in Australia Under Special Access Scheme
LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%
LTR Pharma Requests for Voluntary Suspension Pending Clinical Study Results
LTR Pharma Concludes Final Dose in SPONTAN Study
LTR Pharma Doses First SPONTAN Patients
LTR Pharma Launches Patient Recruitment for Erectile Dysfunction Drug Clinical Study
LTR Pharma Receives Manufacturing Validation for SPONTAN Bioequivalence Study; Shares Down 3%
LTR Pharma to Conduct Bioequivalence Clinical Trial for Spontan in Q1 2024
LTR Pharma to Start Trading on Australian Bourse Following AU$7 Million IPO
No Data